In line with previous reports, c‐Myc protein expression was down‐regulated in prostate cancer cells as early as six hours post‐CUDC‐907 treatment in 22Rv1 and 12 hours in LNCaP, potentially through transcriptional mechanisms (Figure 6A,B and Figure S5). This evidence concerns the gene MYC and prostate cancer.